The antinociceptive and anti-inflammatory activity of
caulerpin was investigated. This bisindole
alkaloid was isolated from the lipoid extract of Caulerpa racemosa and its structure was identified by spectroscopic methods, including IR and NMR techniques. The pharmacological assays used were the writhing and the hot plate tests, the
formalin-induced
pain, the
capsaicin-induced ear
edema and the
carrageenan-induced
peritonitis.
Caulerpin was given orally at a concentration of 100 micromol/kg. In the abdominal constriction test
caulerpin showed reduction in the
acetic acid-induced nociception at 0.0945 micromol (0.0103-1.0984) and for dypirone it was 0.0426 micromol (0.0092-0.1972). In the hot plate test in vivo the inhibition of nociception by
caulerpin (100 micromol/kg, p.o.) was also favorable. This result suggests that this compound exhibits a central activity, without changing the motor activity (seen in the rotarod test).
Caulerpin (100 micromol/kg, p.o.) reduced the
formalin effects in both phases by 35.4% and 45.6%, respectively. The possible anti-inflammatory activity observed in the second phase in the
formalin test of
caulerpin (100 micromol/kg, p.o.) was confirmed on the
capsaicin-induced ear
edema model, where an inhibition of 55.8% was presented. Indeed, it was also observed in the
carrageenan-induced
peritonitis that
caulerpin (100 micromol/kg, p.o.) exhibited anti-inflammatory activity, reducing significantly the number of recruit cells by 48.3%. Pharmacological studies are continuing in order to characterize the mechanism(s) responsible for the antinociceptive and anti-inflammatory actions and also to identify other active principles present in Caulerpa racemosa.